Axios Vitals on MSN4d
Maternal RSV vaccines found to cut infection riskVaccinating pregnant women against RSV reduced the risk of infection in their infants by 61% compared with newborns with ...
The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased ...
Ab&B Bio-Tech has joined the stacked roster of drug developers queuing up to go public in Hong Kong, filing the paperwork for ...
12d
The U.S. Food and Drug Administration now requires and has approved safety labeling changes to the prescribing information ...
Stéphane Bancel, CEO of mRNA specialist Moderna, delivered some difficult truths to shareholders about the company’s ...
While presenting at the JP Morgan Healthcare Conference, Pfizer Inc. (NYSE:PFE) Albert Bourla, Chairman and CEO, said, “I ...
According to CDC researchers, cases of tularemia in the U.S. increased by nearly 60% from 2011 to 2022 compared with the ...
Expectant mothers will have access to free vaccines against respiratory syncytial virus (RSV) from next month under a major ...
Khaleej Times on MSN1d
UAE: Pfizer to expand access to groundbreaking treatments and vaccines in the GulfPfizer said it will 'support capacity-building initiatives, such as training healthcare professionals and advancing clinical ...
HealthDay on MSN12d
Eight in 10 Infants Received RSV Protection in the 2023 to 2024 Season“The availability of two different RSV protection methods in sufficient supply may have ... Several authors disclosed ties to pharmaceutical companies, including Pfizer, which manufactures the RSVpreF ...
Moderna (NASDAQ: MRNA) was one of the hottest companies of early pandemic times, delivering a coronavirus vaccine to market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback